Literature DB >> 16422887

Arteriogenic erectile dysfunction alters protein expression within the cavernosal tissue in an animal model.

Ling De Young1, Anthony Bella, Jeffrey Howard, Gerald Brock.   

Abstract

INTRODUCTION: Erectile dysfunction (ED) is a highly prevalent and often untreated condition. It may be a marker of underlying chronic illness and negatively impacts quality of life. Penile arterial insufficiency, frequently found in association with hypertension, dyslipidemia, diabetes mellitus, pelvic irradiation, trauma, and smoking, is the most common cause of ED. AIM: This study was designed to measure the effect of penile hypoperfusion-induced alteration and injury on erectile tissue at the cellular and protein level.
METHODS: Eighteen 4-month-old male Sprague Dawley rats were placed into three groups (n = 6): sham surgery, unilateral internal iliac artery ligation (UIIAL), and bilateral internal iliac artery ligation (BIIAL). MAIN OUTCOME MEASURE: Erectile function was assessed 4 weeks following arterial ligation surgery as measured by a rise in intracavernosal pressure induced by cavernosal nerve stimulation. Penile tissue alterations were characterized by immunohistochemistry, protein content measured by western blot, and "global" protein expression profile carried out by using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) ProteinChip technology.
RESULTS: Significantly lower intracavernous pressures were demonstrated in animals subjected to UIIAL surgery, which correlated to the extent of artery ligation. The intensity and quantity of immunohistochemical staining for neuronal nitric oxide synthase, endothelial cell integrity, smooth muscle cell alpha-actin, and vascular endothelial growth factor (VEGF) receptor flk1 were decreased in the BIIAL group compared to sham controls. SELDI-TOF-MS analysis revealed changes in molecular expression of a approximately 6,560 Da protein relative to a 7,720 Da protein (peak ratio = 1.34 +/- 0.3, BIIAL; 0.36 +/- 0.1 controls, P < 0.05).
CONCLUSIONS: In this report, an animal model of vascular penile insufficiency demonstrates altered protein expression associated with cavernosal tissue injury and reduced erectile function. Although the clinical significance of these observations is currently undefined, this model may allow greater insight into the complex biologic changes associated with arteriogenic ED in man.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16422887     DOI: 10.1111/j.1743-6109.2005.20229.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  5 in total

Review 1.  Bicycle riding, perineal trauma, and erectile dysfunction: data and solutions.

Authors:  Irwin Goldstein; Alan L Lurie; John P Lubisich
Journal:  Curr Urol Rep       Date:  2007-11       Impact factor: 3.092

2.  Transplantation of endothelial progenitor cells transfected with VEGF165 to restore erectile function in diabetic rats.

Authors:  Xin Gou; Wei-Yang He; Ming-Zhao Xiao; Ming Qiu; Ming Wang; Yuan-Zhong Deng; Chao-Dong Liu; Zao-Bing Tang; Jie Li; Yong Chen
Journal:  Asian J Androl       Date:  2010-11-29       Impact factor: 3.285

3.  The use of proteomics in identifying differentially expressed serum proteins in humans with type 2 diabetes.

Authors:  Tea Sundsten; Michael Eberhardson; Michael Göransson; Peter Bergsten
Journal:  Proteome Sci       Date:  2006-12-12       Impact factor: 2.480

Review 4.  Intracavernous administration of bone marrow mononuclear cells: a new method of treating erectile dysfunction?

Authors:  Thomas E Ichim; Timothy Warbington; Octav Cristea; Joseph L Chin; Amit N Patel
Journal:  J Transl Med       Date:  2013-06-09       Impact factor: 5.531

5.  Molecular and Histologic Evidence of Novel Erectile Dysfunction Rat Model as an Aging Atherosclerosis Model: A Preliminary Study.

Authors:  Jae Heon Kim; Ji Sung Shim; Jong Wook Kim; Seung Whan Doo; Jae Hyun Bae; Ju Han Lee; Yun Seob Song; Je Jong Kim; Du Geon Moon
Journal:  World J Mens Health       Date:  2019-06-14       Impact factor: 5.400

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.